Streetbeat News

Products Services

MCK

McKesson has signed a definitive agreement to acquire a 70% controlling interest in Core Ventures for approximately $2.49 billion in cash. This acquisition will integrate Core Ventures into McKesson's Oncology platform, with financial results reported in the US Pharmaceutical segment.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 12:03 pm

FYBR

Frontier Communications has launched a new 7 Gig fiber internet service, setting a new standard in internet speed and combining it with premium services. This move positions Frontier as a leader in high-speed internet offerings.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 12:02 pm

NRXP

HOPE Therapeutics, a subsidiary of NRx Pharmaceuticals (NASDAQ:NRXP), has secured non-dilutive debt funding to establish a $100M ketamine clinic network. This expansion aims to provide comprehensive mental health care services for conditions like suicidal depression and PTSD.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 12:02 pm

ETHUSD

TONUSD

Telegram founder Pavel Durov's arrest in France has sparked concerns in the tech and crypto communities. French authorities cite Telegram's moderation practices as a reason for the arrest. The Open Network (TON) and crypto figures like Vitalik Buterin and Justin Sun have shown support for Durov.

Portfolio Pulse from Murtuza Merchant

August 26, 2024 | 11:55 am

UCBJF

UCBJY

UCB SA, a European biopharmaceutical company, is divesting its neurology and allergy business in China for $680 million to CBC Group and Mubadala. This strategic move allows UCB to focus on innovation and partnerships in China, with the transaction expected to close in Q4 2024.

Portfolio Pulse from Vandana Singh

August 26, 2024 | 11:51 am

VCEL

Vericel Corporation has received FDA approval for the arthroscopic delivery of its MACI product, enhancing knee cartilage treatment options.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:47 am

ELAB

Elevai Labs' stock is trading higher following the successful completion of a clinical study on the effectiveness of Elevai exosomes for facial appearance improvement.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:46 am

BA

GD

LMT

NOC

PPA

RTX

XAR

Defense companies like Lockheed Martin, RTX, and others are expected to see a significant increase in cash flow due to rising geopolitical tensions, with projections of $52 billion by 2026. This growth is driven by increased military spending in response to global conflicts.

Portfolio Pulse from Benzinga Neuro

August 26, 2024 | 11:43 am

RIVN

A fire at Rivian's Illinois plant damaged several vehicles but did not affect the plant itself. No injuries were reported. The plant is Rivian's only operational facility, with plans for a new plant in Georgia currently on hold.

Portfolio Pulse from Anan Ashraf

August 26, 2024 | 11:43 am

NNVC

NanoViricides, Inc. is exploring the use of its antiviral drug NV-387 for treating MPOX under the WHO MEURI protocol amid a global outbreak. NV-387 has shown promising results in safety and effectiveness in preclinical trials, potentially positioning it as a revolutionary treatment for various viral infections.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:39 am